News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
249,463 Results
Type
Article (15650)
Company Profile (22)
Press Release (233855)
Multimedia
Podcasts (29)
Webinars (6)
Section
Business (77526)
Career Advice (662)
Deals (11838)
Drug Delivery (45)
Drug Development (32623)
Employer Resources (72)
FDA (5750)
Job Trends (5045)
News (118389)
Policy (9588)
Tag
2027 Genetown Standard (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (1209)
Academic (1)
Accelerated approval (19)
ADA (17)
Adcomms (15)
Allergies (86)
Alliances (17332)
ALS (99)
Alzheimer's disease (628)
Antibody-drug conjugate (ADC) (197)
Approvals (6047)
Artificial intelligence (211)
ASCO (137)
Autoimmune disease (120)
Automation (21)
Bankruptcy (82)
Best Places to Work (4200)
BIO (25)
Biologics (1)
BIOSECURE Act (8)
Biosimilars (108)
BioSpace Insights (50)
Biotechnology (11)
Bladder cancer (88)
Brain cancer (30)
Breast cancer (300)
Cancer (2358)
Cardiovascular disease (227)
Career advice (579)
Career pathing (24)
CAR-T (111)
CDC (29)
Celiac Disease (2)
Cell therapy (299)
Cervical cancer (23)
Clinical research (30018)
Collaboration (740)
Commercialization (4)
Company closure (2)
Compensation (190)
Complete response letters (24)
COVID-19 (1303)
CRISPR (37)
C-suite (445)
Cystic fibrosis (39)
Data (3678)
Decentralized trials (1)
Denatured (13)
Depression (57)
Dermatology (50)
Diabetes (288)
Diagnostics (2380)
Digital health (22)
Diversity (10)
Diversity, equity & inclusion (30)
Drug discovery (110)
Drug pricing (64)
Drug shortages (19)
Duchenne muscular dystrophy (119)
Earnings (26665)
Editorial (32)
Employer branding (5)
Employer resources (70)
Events (34107)
Executive appointments (428)
FDA (7283)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (5)
Frontotemporal dementia (5)
Funding (670)
Gene editing (69)
Generative AI (17)
Gene therapy (264)
GLP-1 (431)
Government (1468)
Grass and pollen (3)
Guidances (185)
Healthcare (6714)
Hematology (84)
HIV (57)
Huntington's disease (24)
IgA nephropathy (45)
Immunology and inflammation (98)
Immuno-oncology (34)
Indications (81)
Infectious disease (1465)
Inflammatory bowel disease (96)
Inflation Reduction Act (6)
Influenza (65)
Intellectual property (70)
Interviews (112)
IPO (4838)
IRA (23)
Job creations (1020)
Job search strategy (485)
JPM (18)
Kidney cancer (11)
Labor market (32)
Layoffs (136)
Leadership (25)
Legal (1852)
Licensing (1)
Liver cancer (45)
Longevity (8)
Lung cancer (311)
Lymphoma (234)
Machine learning (17)
Management (26)
Manufacturing (393)
Marketing (9)
MASH (106)
Medical affairs (1)
Medical device (4489)
Medtech (4555)
Mergers & acquisitions (7511)
Metabolic disorders (660)
mRNA (61)
Multiple sclerosis (108)
NASH (16)
Neurodegenerative disease (143)
Neuropsychiatric disorders (30)
Neuroscience (1261)
NextGen: Class of 2026 (2372)
Non-profit (1958)
Now hiring (12)
Obesity (261)
Opinion (80)
Ovarian cancer (95)
Pain (83)
Pancreatic cancer (89)
Parkinson's disease (153)
Partnered (16)
Patents (105)
Patient recruitment (277)
Peanut (30)
People (22871)
Pharmaceutical (11)
Pharmacy benefit managers (15)
Phase 1 (6980)
Phase 2 (12962)
Phase 3 (12096)
Pipeline (3880)
Policy (140)
Postmarket research (1211)
Preclinical (2510)
Press Release (44)
Prostate cancer (150)
Psychedelics (27)
Radiopharmaceuticals (125)
Rare diseases (444)
Real estate (2088)
Recruiting (26)
Regulatory (8497)
Reports (24)
Research institute (1091)
Resumes & cover letters (88)
Rett syndrome (7)
RNA editing (3)
RSV (49)
Schizophrenia (74)
Series A (142)
Series B (85)
Service/supplier (2)
Sickle cell disease (39)
Special edition (5)
Spinal muscular atrophy (80)
Sponsored (15)
Startups (1503)
Stomach cancer (6)
Supply chain (45)
Tariffs (21)
The Weekly (16)
Vaccines (538)
Venture capital (44)
Weight loss (167)
Women's health (64)
Worklife (10)
Date
Today (21)
Last 7 days (184)
Last 30 days (670)
Last 365 days (10261)
2026 (6043)
2025 (10437)
2024 (12398)
2023 (13201)
2022 (20833)
2021 (21383)
2020 (19853)
2019 (16987)
2018 (12756)
2017 (11652)
2016 (11329)
2015 (13614)
2014 (9530)
2013 (7626)
2012 (8445)
2011 (9027)
2010 (7757)
Location
Africa (315)
Alabama (19)
Alaska (5)
Arizona (95)
Arkansas (2)
Asia (19564)
Australia (3180)
California (4510)
Canada (1122)
China (761)
Colorado (179)
Connecticut (198)
Delaware (227)
Europe (41316)
Florida (595)
Georgia (174)
Hawaii (1)
Idaho (16)
Illinois (444)
India (60)
Indiana (240)
Iowa (2)
Japan (360)
Kansas (48)
Kentucky (21)
Louisiana (19)
Maine (13)
Maryland (524)
Massachusetts (3132)
Michigan (155)
Minnesota (249)
Missouri (79)
Montana (7)
Nebraska (8)
Nevada (49)
New Hampshire (16)
New Jersey (1479)
New Mexico (7)
New York (1210)
North Carolina (471)
North Dakota (1)
Northern California (2203)
Ohio (122)
Oklahoma (5)
Oregon (4)
Pennsylvania (1015)
Puerto Rico (10)
Rhode Island (8)
South America (428)
South Carolina (12)
Southern California (1914)
Tennessee (64)
Texas (542)
United States (16133)
Utah (137)
Virginia (82)
Washington D.C. (9)
Washington State (445)
Wisconsin (42)
Wyoming (2)
249,463 Results for "menarini asia pacific group formerly invida group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ACG appoints Lalit Kasliwal as Group Chief Financial Officer
New Group Chief Financial Officer to support next phase of international growth
July 29, 2026
·
1 min read
Press Releases
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
July 24, 2026
·
9 min read
Press Releases
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
July 14, 2026
·
4 min read
Press Releases
Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
May 14, 2026
·
20 min read
Press Releases
Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
June 15, 2026
·
7 min read
Press Releases
Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor (NEXPOVIO®) Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
June 15, 2026
·
12 min read
Press Releases
Brenus Pharma Welcomes New European and Asia-Pacific Life Sciences Investors in Series A Extension
July 20, 2026
·
1 min read
Press Releases
Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region
July 20, 2026
·
10 min read
Press Releases
Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026
June 19, 2026
·
3 min read
Press Releases
Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
May 28, 2026
·
8 min read
1 of 24,947
Next
